Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Phorm Announces Board Changes

1 Dec 2008 07:00

RNS Number : 2435J
Phorm Inc
01 December 2008
Β 

Phorm, Inc. ("Phorm" or the "Company")

Phorm Announces Board ChangesΒ 

Phorm (AIM: PHRM and PHRX), the advertising technology company, announces the following changes to the Company's Board:

Norman Lamont is appointed to the Board as a Non-Executive Director. Mr. Lamont was a Cabinet Minister under both Margaret Thatcher and John Major, served as Chancellor of the Exchequer from 1990 to 1993 and was a member of the House of Commons for twenty-fiveΒ years.

Kip Meek,Β currently Chairman of the Broadband Stakeholders Group and of Ingenious Consulting Network, joins theΒ BoardΒ as a Non-Executive Director. From 2003 until 2007, he was an Executive Board member of Ofcom. Mr. Meek was previously Managing Director of Spectrum Strategy Consultants and Partner at Coopers & Lybrand, where he led the Media and Telecoms practice.

Stefan Allesch-Taylor, Chief Executive of Fairfax, an international, independent investment bank, is appointed a Non-Executive Director on the Board. As one of the founders ofΒ Fairfax, he has a strong business background and considerable AIM market experience.

Stephen Partridge-HicksΒ is appointed to the Board as a Non-Executive Director. Mr. Partridge-Hicks is the co-founder and Managing Director of Gordian Knot, an FSA regulated investment management company registered in England. Prior to establishing Gordian Knot and Sigma Finance Corporation, a $57 billion investment fund, he worked at Citibank in London. He has extensive knowledge and experience within the financial sector in the UK.

StevenΒ Heyer,Β DavidΒ Dorman, Christopher Lawrence and Virasb VahidiΒ willΒ step down from the Board with immediate effect. Virasb Vahidi, Chief Operating Officer,Β willΒ also leave the Company with immediate effect.

Messrs. Heyer,Β Dorman, LawrenceΒ and VahidiΒ will takeΒ this action as a result of differences with Mr. Ertugrul as toΒ the management and future direction of the Company.

Kent Ertugrul, CEO of Phorm, commented: "I would like to thankΒ Steve,Β Dave, ChrisΒ and Virasb for the important contributionsΒ they have made to Phorm's development.Β Β Their skills, experience and contacts have been immensely valuable and have been instrumental in the great strides we have made in developing the Company's strategy and building relationships with ISPs, advertisers and publishers.

"Meanwhile,Β I welcome Lord Lamont, Kip,Β StefanΒ and StephenΒ to the Board. They bring extensive experience on government, business, regulatory matters and financial markets. As we move into the next phase of our development, the priority will be to build momentum in the rollout of our strategy. The new Board members that we are announcing today will play an important role in helping us to achieveΒ theΒ Company'sΒ goals."

Save as set out in the Appendix, there are no further details in relation to the above appointments which require disclosure under paragraph (g) of Schedule 2 to the AIM Rules.

NOTES TO EDITORS:

For Phorm Enquiries:Β 

Investor Relations +44 (0) 207 297 2067

Brunswick Group

Craig Breheny +44 (0) 20 7404 5959Azhar Khan

Citigate Dewe Rogerson +44Β (0)Β 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited +44Β (0)Β 20 7050 6500Β 

(Nominated Adviser)Β 

Mark WilliamsΒ 

Andrew ChubbΒ 

About Phorm:Β 

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users'Β personal privacy and security.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is aΒ DelawareΒ corporation with offices inΒ New York,Β LondonΒ andΒ Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

Appendix

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

1. Details of full name, age, previous names:

Full Name: Stefan Paul Allesch-Taylor

Age: 39

Β 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

Powderblue Pictures LtdΒ -Β presentΒ 

Fairfax I.S. PLC (formerly Fairfax I.S. management Ltd)Β -Β presentΒ 

Fairfax Group LtdΒ -Β presentΒ 

Fairfax Capital LtdΒ -Β presentΒ 

Tactica Fund PCC PLCΒ -Β presentΒ 

Tactica Fund Management LtdΒ -Β presentΒ 

Fairfax Investment Management LimitedΒ -Β presentΒ 

Develica Management Ltd - Resigned:Β 30/06/05Β 

Accsys Technologies PLC - Resigned:Β 09/05/07

Savoy Asset Management Ltd - Resigned:Β 10/04/06Β 

Library of Life (Europe) Ltd - Resigned:Β 28/01/04

Tactica Advisory (UK) Ltd - Resigned:Β 17/09/08Β 

*Medicsight Inc - Resigned:Β 08/12/03

1. Details of full name, age, previous names

Full Name: Richard Stephen Partridge-Hicks ("Stephen Partridge-Hicks")

Age: 51

Previous name: Richard Stephen Hicks

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner:

Gordian Knot Limited

Sigma Finance Corporation

1. Details of full name, age, previous names

Full Name: Norman Stewart Hughson Lamont (The Right Hon. Lord Lamont of Lerwick)

Age: 66

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner:

Balli Group plc - present

Compagnie internationale de participations bancaires et financiers SA (CIPAF) - present

RAB Capital plc - present

Jupiter Second Split - present

Jupiter Adria - present

Small Companies Dividend Trust PLC - present

Pantin Hotels Management Ltd - present

Jupiter Off-shore Portfolio Fund Limited - present

Union Resources Limited - present

BancaΒ Commerciala Robank,Β RomaniaΒ - Resigned: 2005

European Growth & Income Trust - Resigned: 2005

Jupiter Finance and Income Trust - Resigned: 2005

East European Food Fund - Resigned: 2005

Galileo plc - Resigned: 2005

Scottish Re Group Limited - Resigned: 2007

1. Details of full name, age, previous names

Full Name: Kingsley John Neville Meek ("Kip")

Age: 53

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAWUGMGGUPRPPU
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.